HIV-positive TB patients on ART (antiretroviral therapy) in Kyrgyzstan
Kyrgyzstan: HIV-positive TB patients on ART (antiretroviral therapy) was 85.0% in 2024. ▲ Rising
Latest (2024)
85.0%
Change on year
up 14.9%
World rank
106th
of 144 countries
All-time high
94.0%
in 2015
All-time low
22.0%
in 2009
Years of data
16
2009–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Kyrgyzstan, 2009–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hiv-positive tb patients on art (antiretroviral therapy) in Kyrgyzstan stood at 85.0%.
The figure is up 14.9% on the previous year and up 66.7% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Kyrgyzstan peaked at 94.0% in 2015 and was at its lowest, 22.0%, in 2009.
Kyrgyzstan ranks 106th of 144 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 16 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Kyrgyzstan, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 22.0% | — |
| 2010 | 37.0% | +68.2% |
| 2011 | 86.0% | +132.4% |
| 2012 | 78.0% | -9.3% |
| 2013 | 54.0% | -30.8% |
| 2014 | 51.0% | -5.6% |
| 2015 | 94.0% | +84.3% |
| 2016 | 69.0% | -26.6% |
| 2017 | 55.0% | -20.3% |
| 2018 | 71.0% | +29.1% |
| 2019 | 72.0% | +1.4% |
| 2020 | 67.0% | -6.9% |
| 2021 | 61.0% | -9.0% |
| 2022 | 82.0% | +34.4% |
| 2023 | 74.0% | -9.8% |
| 2024 | 85.0% | +14.9% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 85.0% is below the median for lower middle income countries, which is 96.0%, 89% of the median. (43 countries reporting)
- Kyrgyzstan's 85.0% is below the median for Europe & Central Asia, which is 96.5%, 88% of the median. (24 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 22.0% | 22.0% | 22.0% | 1 |
| 2010s | 66.7% | 37.0% | 94.0% | 10 |
| 2020s | 73.8% | 61.0% | 85.0% | 5 |
Countries ranked near Kyrgyzstan
More health data for Kyrgyzstan
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 938.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 278 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0501 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.01 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Kyrgyzstan?
- Hiv-positive tb patients on art (antiretroviral therapy) in Kyrgyzstan was 85.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Kyrgyzstan?
- The highest recorded value was 94.0% in 2015.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Kyrgyzstan?
- The lowest recorded value was 22.0% in 2009.
- How does Kyrgyzstan rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Kyrgyzstan ranks 106th out of 144 countries with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Kyrgyzstan?
- Over the last ten years it is up 66.7%. The long-run trend across the full record is rising.
- Where does this Kyrgyzstan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).